1,945
Views
35
CrossRef citations to date
0
Altmetric
Research Paper

Lactic acid production by Streptococcus thermophilus alters Clostridium difficile infection and in vitro Toxin A production

, , , , &
Pages 523-529 | Published online: 16 Aug 2012

References

  • Baxter R, Ray GT, Fireman BH. Case-control study of antibiotic use and subsequent Clostridium difficile-associated diarrhea in hospitalized patients. Infect Control Hosp Epidemiol 2008; 29:44 - 50; http://dx.doi.org/10.1086/524320; PMID: 18171186
  • O’Connor JR, Johnson S, Gerding DN. Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology 2009; 136:1913 - 24; http://dx.doi.org/10.1053/j.gastro.2009.02.073; PMID: 19457419
  • Cartman ST, Heap JT, Kuehne SA, Cockayne A, Minton NP. The emergence of ‘hypervirulence’ in Clostridium difficile. Int J Med Microbiol 2010; 300:387 - 95; http://dx.doi.org/10.1016/j.ijmm.2010.04.008; PMID: 20547099
  • Pawlowski SW, Archbald-Pannone L, Carman RJ, Alcantara-Warren C, Lyerly D, Genheimer CW, et al. Elevated levels of intestinal inflammation in Clostridium difficile infection associated with fluoroquinolone-resistant C. difficile. J Hosp Infect 2009; 73:185 - 7; http://dx.doi.org/10.1016/j.jhin.2009.05.013; PMID: 19709778
  • McFarland LV. Evidence-based review of probiotics for antibiotic-associated diarrhea and Clostridium difficile infections. Anaerobe 2009; 15:274 - 80; http://dx.doi.org/10.1016/j.anaerobe.2009.09.002; PMID: 19825425
  • Gao XW, Mubasher M, Fang CY, Reifer C, Miller LE. Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients. Am J Gastroenterol 2010; 105:1636 - 41; http://dx.doi.org/10.1038/ajg.2010.11; PMID: 20145608
  • Hickson M, D’Souza AL, Muthu N, Rogers TR, Want S, Rajkumar C, et al. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ 2007; 335:80; http://dx.doi.org/10.1136/bmj.39231.599815.55; PMID: 17604300
  • Petrof EO. Probiotics and gastrointestinal disease: Clinical evidence and basic science. Antiinflamm Antiallergy Agents Med Chem 2009; 8:260 - 9; PMID: 20890386
  • Fontaine L, Hols P. The inhibitory spectrum of thermophilin 9 from Streptococcus thermophilus LMD-9 depends on the production of multiple peptides and the activity of BlpG(St), a thiol-disulfide oxidase. Appl Environ Microbiol 2008; 74:1102 - 10; http://dx.doi.org/10.1128/AEM.02030-07; PMID: 18156339
  • Surawicz CM, McFarland LV, Greenberg RN, Rubin M, Fekety R, Mulligan ME, et al. The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Clin Infect Dis 2000; 31:1012 - 7; http://dx.doi.org/10.1086/318130; PMID: 11049785
  • McFarland LV, Surawicz CM, Greenberg RN, Fekety R, Elmer GW, Moyer KA, et al. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA 1994; 271:1913 - 8; http://dx.doi.org/10.1001/jama.1994.03510480037031; PMID: 8201735
  • Chen X, Katchar K, Goldsmith JD, Nanthakumar N, Cheknis A, Gerding DN, et al. A mouse model of Clostridium difficile-associated disease. Gastroenterology 2008; 135:1984 - 92; http://dx.doi.org/10.1053/j.gastro.2008.09.002; PMID: 18848941
  • Rul F, Ben-Yahia L, Chegdani F, Wrzosek L, Thomas S, Noordine ML, et al. Impact of the metabolic activity of Streptococcus thermophilus on the colon epithelium of gnotobiotic rats. J Biol Chem 2011; 286:10288 - 96; http://dx.doi.org/10.1074/jbc.M110.168666; PMID: 21239485
  • Corthier G, Dubos F, Raibaud P. Modulation of cytotoxin production by Clostridium difficile in the intestinal tracts of gnotobiotic mice inoculated with various human intestinal bacteria. Appl Environ Microbiol 1985; 49:250 - 2; PMID: 3977313
  • Banerjee P, Merkel GJ, Bhunia AK. Lactobacillus delbrueckii ssp. bulgaricus B-30892 can inhibit cytotoxic effects and adhesion of pathogenic Clostridium difficile to Caco-2 cells. Gut Pathog 2009; 1:8; http://dx.doi.org/10.1186/1757-4749-1-8; PMID: 19397787
  • Naaber P, Smidt I, Stsepetova J, Brilene T, Annuk H, Mikelsaar M. Inhibition of Clostridium difficile strains by intestinal Lactobacillus species. J Med Microbiol 2004; 53:551 - 4; http://dx.doi.org/10.1099/jmm.0.45595-0; PMID: 15150337
  • Trejo FM, Minnaard J, Perez PF, De Antoni GL. Inhibition of Clostridium difficile growth and adhesion to enterocytes by Bifidobacterium supernatants. Anaerobe 2006; 12:186 - 93; http://dx.doi.org/10.1016/j.anaerobe.2006.03.004; PMID: 16759886
  • Trejo FM, Pérez PF, De Antoni GL. Co-culture with potentially probiotic microorganisms antagonises virulence factors of Clostridium difficile in vitro. Antonie Van Leeuwenhoek 2010; 98:19 - 29; http://dx.doi.org/10.1007/s10482-010-9424-6; PMID: 20232250
  • Chen CY, Nace GW, Irwin PL. A 6 x 6 drop plate method for simultaneous colony counting and MPN enumeration of Campylobacter jejuni, Listeria monocytogenes, and Escherichia coli. J Microbiol Methods 2003; 55:475 - 9; http://dx.doi.org/10.1016/S0167-7012(03)00194-5; PMID: 14529971
  • Pawlowski SW, Calabrese G, Kolling GL, Platts-Mills J, Freire R, AlcantaraWarren C, et al. Murine model of Clostridium difficile infection with aged gnotobiotic C57BL/6 mice and a BI/NAP1 strain. J Infect Dis 2010; 202:1708 - 12; http://dx.doi.org/10.1086/657086; PMID: 20977342
  • Houser BA, Hattel AL, Jayarao BM. Real-time multiplex polymerase chain reaction assay for rapid detection of Clostridium difficile toxin-encoding strains. Foodborne Pathog Dis 2010; 7:719 - 26; http://dx.doi.org/10.1089/fpd.2009.0483; PMID: 20113206
  • Metcalf D, Sharif S, Weese JS. Evaluation of candidate reference genes in Clostridium difficile for gene expression normalization. Anaerobe 2010; 16:439 - 43; http://dx.doi.org/10.1016/j.anaerobe.2010.06.007; PMID: 20599622
  • Antonopoulos DA, Huse SM, Morrison HG, Schmidt TM, Sogin ML, Young VB. Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect Immun 2009; 77:2367 - 75; http://dx.doi.org/10.1128/IAI.01520-08; PMID: 19307217

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.